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Summary
 
The neisserial porin P.I is a GTP binding protein that forms a voltage-gated channel that trans-
locates into mammalian cell membranes and modulates host cell signaling events. Here, we re-
port that P.I confers invasion of the bacterial pathogen 
 
Neisseria gonorrhoeae 
 
into Chang epithe-
lial cells and that this event is controlled by GTP, as well as other phosphorus-containing
compounds. Bacterial invasion was observed only for strains carrying the P.IA subtype of porin,
which is typically associated with the development of disseminated neisserial disease, and did
not require opacity outer membrane proteins, previously recognized as gonococcal invasins.
Allelic replacement studies showed that bacterial invasiveness cotransferred with the P.IA
(
 
por1A
 
) gene. Mutation of the P.I-associated protein Rmp did not alter the invasive properties.
Cross-linking of labeled GTP to the porin revealed more efficient GTP binding to the P.IA
than P.IB porin subtype. GTP binding was inhibited by an excess of unlabeled GTP, ATP, and
GDP, as well as inorganic phosphate, but not by UTP or beta-glycerophosphate, fully in line
with the respective invasion-inhibitory activities observed for these compounds. The P.IA-
mediated cellular invasion may explain the more invasive behavior of P.IA strains in the natural
infection and may broaden the basis for the development of a P.I-based gonococcal vaccine.
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T
 
he bacterial pathogen 
 
Neisseria gonorrhoeae
 
 has evolved
an array of sophisticated machineries to optimally sur-
vive within the human host. Some of its more prominent
adaptive strategies are the maintenance of extensive reper-
toire of antigenic variation, which may serve to evade the
human host defense, and the controlled on- and off-
switching (phase variation) of distinct cell surface mole-
cules, which may enable the pathogen to colonize various
infection niches (for reviews see references 1–3). The phe-
notypic diversity is largely driven by genetic mechanisms,
including allelic exchange between related loci (4, 5) and a
mispairing of nucleotide repeats located within, or in close
proximity to, the coding regions for relevant surface anti-
gens. The latter mechanism leads to reversible shifts of
open reading frames (ORFs)
 
1
 
 and thus variable expression
of the antigens (6–10). Major variable surface components
include pili (fimbriae), the pilus-associated adhesin PilC,
the opacity protein (Opa) family of bacterial adhesins, and
LPS. These factors are thought to be key players in bacte-
rial adherence to and invasion of mammalian cells and to
contribute to the cell tropism displayed by the pathogen,
and may confer bacterial resistance to complement-medi-
ated killing (11–19). Evidence is accumulating that the in-
trinsic neisserial surface variation may be further compli-
cated by a bacterial phenotype-dependent recruitment of
host molecules such as sialic acids, vitronectin, fibronectin,
transferrin, sulfated polysaccharides, and complement fac-
tors (16, 17, 20–27). This strategy may further limit bacte-
rial antigen exposure and determine the sensitivity of the
pathogen to host defense mechanisms. The binding of sev-
eral of these factors by the microorganisms has been re-
ported to open additional pathways for cellular invasion
(20–23, 26). The highly flexible neisserial phenotype is
thought to be one of the major obstacles in the develop-
ment of a protective host immune response.
One of the neisserial surface antigens that is stably ex-
pressed by a given strain is the principal outer membrane
protein P.I (for review see reference 28). Because of its in-
variable presence at the bacterial cell surface, its compara-
tively conserved nature, and its abundance in the outer
membrane, P.I has gained much attention as a potential
vaccine candidate antigen (29–34). Indeed, molecular epi-
 
1
 
Abbreviations used in this paper:
 
 AHU, arginine-hypoxanthine-uracil;
DPBS, Dulbecco’s phosphate buffered saline; Opa, opacity outer mem-
brane protein; ORF, open reading frame.
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demiology studies suggest that P.I-specific antibodies that
develop during the natural infection may provide partial
protection against reinfection with gonococci of the same
P.I serotype (35). On the basis of structural and immu-
nochemical characteristics, two major subtypes of P.I have
been recognized, termed P.IA and P.IB, which are en-
coded by the mutually exclusive alleles 
 
por1A
 
 and 
 
por1B
 
.
The P.I subtypes vary slightly in size among strains with
molecular masses ranging from 32,000 to 38,000 daltons
and act as membrane pores enabling the flux of ions and
small macromolecules across the membrane barrier (36,
37). The porin function of P.I has been confirmed by con-
ductance experiments in which purified P.I was incorpo-
rated into lipid bilayers and demonstrated to form a volt-
age-gated channel with slight anion selectivity (38, 39).
Interestingly, these channels also form when viable micro-
organisms are added to the lipid bilayer system, suggesting
transfer of the protein from the bacteria into the artificial
membrane (40). Purified P.I also inserts into plasma mem-
branes of eukaryotic cells. The addition of purified P.I to
mammalian cells causes a transient change in transmem-
brane potential and modulates host cell signaling events
(36, 41–44), but direct evidence for insertion of a func-
tional pore upon infection of mammalian cells with intact
microorganisms is not available.
The possible function of P.I in the natural infection is
not well established. Strains bearing P.IA are much more
commonly isolated from patients with disseminated gono-
coccal disease than P.IB strains (45–48), suggesting a differ-
ence in virulence related to the P.I subtype. The molecular
basis for the more invasive behavior of P.IA strains is un-
known, although these strains are usually more resistant to
killing by normal human serum (48–51) and show up to a
10-fold increase in the rate of P.I translocation into lipid
bilayers compared with P.IB strains (40). On theoretical
grounds, the latter event has been speculated to facilitate
bacterial invasion of mammalian cells, possibly by spiking
the plasma membrane and activating a phagocytosis-like
event (36, 44, 52, 53). However, true evidence for a role of
P.I in neisserial invasion of human cells is lacking. In this
study, we addressed this topic and identified a novel inva-
sion mechanism for 
 
Neisseria gonorrhoeae
 
 that involves P.I
and that is unique to strains bearing P.IA. This uptake
mechanism does not require the family of Opa proteins
previously recognized as gonococcal invasins and becomes
apparent under conditions of low phosphate only. Our data
provide the first direct evidence for a role of porins in bac-
terial invasion of eukaryotic cells and may explain the abil-
ity of the pathogen to spread from the primary focus of in-
fection towards distant body sites, a feature that is typically
associated with P.IA strains. The data lend further support
for the development of a P.I-based gonococcal vaccine.
 
Materials and Methods
 
Bacterial Strains and Cell Culture.
 
The strains used in this study
are listed in Table 1. The VP1-Opa variants have been described
previously (12, 13). All microorganisms were routinely grown on
GC agar plates (26) for 12 to 14 h at 37
 
8
 
C in a 5% CO
 
2
 
 atmo-
sphere. All strains were nonpiliated. Opa variants were selected
based on colonial opacity and the Opa phenotype was verified by
SDS-PAGE, immunoblotting, and proteoglycan receptor binding
(see below). For use in infection experiments, bacteria were
grown to exponential growth phase in 50-ml polypropylene
tubes containing 10 ml of Hepes medium (26) enriched with
0.5% IsoVitaleX (BBL, Cockeysville, MD) for 3 h at 37
 
8
 
C in a
gyrotory water bath shaker (125 rpm) to remove contaminating
agar polysaccharides (24). Iron starvation of strain VP1 was im-
posed by adding Deferoxamine (30 
 
m
 
M final concentration;
Sigma Chemical Co., St. Louis, MO) to Hepes medium lacking
IsoVitaleX. Arginine-hypoxanthine-uracil (AHU) starvation was
imposed by growing the AHU-requiring strain FA19 in Hepes
medium lacking IsoVitaleX for 3 h. Use of various phosphate
sources for bacterial growth was determined using a chemically
defined medium (54) in which phosphate was made the growth
limiting constituent. Human Chang conjunctiva epithelial cells
(CCL20.2; American Type Culture Collection, Rockville, MD)
were maintained in 25-cm
 
2
 
 tissue culture flasks (Corning Glass
Works, Corning, NY) in 5 ml RPMI 1640 (GIBCO BRL,
Gaithersburg, MD) plus 5% fetal bovine serum (FBS) at 37
 
8
 
C in
10% CO
 
2
 
 incubator. For use in infection experiments, cells were
cultured for 2 to 3 d to near confluence on circular (12-mm di-
ameter) glass coverslips in RPMI 1640 plus 5% FCS in 24-well
tissue culture plates.
 
Genetic Engineering.
 
The construction of the strains FA6611,
FA6616, FA6564, and FA6571 carrying recombinant P.I protein
with a minitransposon mTn
 
3
 
-Cm-3 located downstream of the
 
por
 
 gene has been described previously (49). For construction of
Rmp null mutants, the 
 
rmp
 
 gene of strain MS11 was PCR ampli-
fied with the upstream primer JHC100 (5
 
9
 
-CTATCCGATTT-
GCCGCCATGTTTC-3
 
9
 
) in combination with the downstream
primer JHC101 (5
 
9
 
-CCGCGGGGTTTCAACCGAAAAGGG-
 
Table 1.
 
Bacterial Strains Used in this Study
 
Strain P.I phenotype Source Reference
VP1 P.IA J.P.M. van Putten 12, 52
NRL 7122 P.IA T.M. Buchanan 77
NRL 8658 P.IA T.M. Buchanan 77
NRL 7929 P.IA T.M. Buchanan 77
80 P.IA J.P.M. van Putten –
FA19 P.IA P.F. Sparling 49
MS11 P.IB T.F. Meyer 12
VP2 P.IB J.P.M. van Putten –
5590 P.IB J.P.M. van Putten 78
F-62 P.IB T.M. Buchanan 77
1291 P.IB M.A. Apicella 77
FA1090 P.IB J.G. Cannon 79
FA6616 (MS11) P.IB
 
(MS11)
 
C. Elkins 49
FA6611 (MS11) P.IA
 
(FA19)
 
C. Elkins 49
FA6564 (FA19) P.IA
 
(FA19)
 
C. Elkins 49
FA6571 (FA19) P.IB
 
(MS11)
 
C. Elkins 49 
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9
 
) using the Expand
 
Ô
 
 High Fidelity PCR System (Boehringer
Mannheim Corp., Indianapolis, IN), and cloned into the pCR2.1
vector (Invitrogen, Carlsbad, CA). A mutated 
 
rmp
 
 was created by
removing a 675-bp internal fragment from the subclone using the
unique BsiWI site in 
 
rmp
 
 and a flanking ClaI site, thus deleting all
but 121 bp on the 5
 
9
 
 end of the 
 
rmp
 
 ORF, and replacing it with a
1,098-bp fragment containing a chloramphenicol resistance 
 
cat
 
cassette (see Fig. 4 
 
A
 
). This cassette was originally PCR amplified
from plasmid pACYC184 (New England Biolabs, Beverly, MA)
using the primers JHC110 (5
 
9
 
-CCAAGCTTCAGACGGCGA-
ATTTCTGCCATTCATCCGC-3
 
9
 
) and JHC123 (5
 
9
 
-GCTGG-
TAATGTTCTTGCATGGTC-3
 
9
 
), which introduced terminal
HindIII sites and a gonococcal DNA uptake sequence. Insertion
in the 
 
rmp
 
 gene was established by filling in the sticky ends
through the use of DNA polymerase I (Klenow fragment), fol-
lowed by blunt-end ligation, creating plasmid pCR2.1-
 
D
 
rmp
 
::
 
cat
 
,
in which the 
 
cat
 
 insert was in the same direction as the 
 
rmp 
 
ORF.
Transformation of the mutant allele into MS11 recombinant
strains carrying either P.IA or P.IB was done by transformation of
linearized, AvaII-digested plasmid. Deletion of 
 
rmp
 
 was verified
by PCR, restriction analysis of the PCR product, and immuno-
blotting using an Rmp-specific antibody (see Fig. 4 
 
B
 
).
 
Electrophoresis, Immunoblotting, and ELISA.
 
The P.I, Opa, and
Rmp phenotypes of the various strains were verified by SDS-
PAGE and/or immunoblotting of whole cell lysates as previously
described (13). After protein transfer, nitrocellulose blots were in-
cubated with the appropriate P.IA (mAb 1EA), P.IB (mAb 5.51),
Rmp (mAb 4C7E), or Opa (mAb4B12/CII) protein-specific
mAbs, and antibody binding was detected with goat anti–mouse
IgG (Fab specific) horseradish peroxidase (HRP) conjugate (1:
2,500 dilution; Sigma Chemical Co.) and Supersignal (Pierce
Chemical Co., Rockford, IL). The mAbs 5.51 and 1EA were
provided by Dr. C. Elkins (University of North Carolina, Chapel
Hill, NC); mAb 4B12/CII was a gift from Dr. M. Achtman
(Max-Planck-Institut für molekulare Genetik, Berlin, Germany).
mAb 4C7E was raised as previously described (13). The P.I phe-
notype of the various strains was verified by whole-cell ELISA,
which involved the air-drying of a suspension of gonococci in
Dulbecco’s PBS (DPBS; 10
 
8
 
 gonococci per well) onto Immulon
4 microtiter plates (Dynatech Labs., Inc., Chantilly, VA), fol-
lowed by sequential incubations (1 h, 37
 
8
 
C) in 100 
 
m
 
l of DPBS/
3% BSA, 100 
 
m
 
l of DPBS/0.5% BSA/0.05% Tween 20 plus
P.IA- or P.IB-specific mAb, and 100 
 
m
 
l of DPBS/0.5% BSA/
0.05% Tween 20 plus goat anti–mouse IgG peroxidase conjugate.
Antibody binding was detected by the addition of 150 
 
m
 
l of
 
O
 
-phenylenediamine in citric acid phosphate buffer (pH 5.0).
Reactions were stopped with 50 
 
m
 
l of 4 N H
 
2
 
SO
 
4
 
, and results
were read with a Titertek Multiscan ELISA reader (Titertek In-
struments, Huntsville, AL). LPS phenotypes were analyzed by
Urea–SDS-PAGE and silverstaining (16).
 
Proteoglycan Receptor Binding.
 
Binding of epithelial heparan
sulfate proteoglycan receptors by gonococcal Opa variants was as-
sessed as described previously (55). In brief, Chang cells were
metabolically labeled during growth in 75-cm
 
2
 
 tissue culture
flasks in 10 ml of Basal Medium Eagle supplemented with 1%
FCS, 1% nonessential amino acids, and 30 
 
m
 
Ci 
 
35
 
SO
 
4
 
. After 48 h,
cells were washed with medium and the extracellular proteogly-
can receptor fragment (ectodomain) was isolated from the cells
using trypsin. Ectodomain binding was measured by incubating
5 
 
3 
 
10
 
7
 
 gonococci with labeled receptor fragment in 150 
 
m
 
l of
Hepes buffer (10 mM Hepes, 140 mM NaCl, 2.5 mM KCl, 5 mM
glucose, 1 mM CaCl
 
2
 
, and 1 mM MgCl
 
2
 
, pH 7.4), for 10 min at
20
 
8
 
C, followed by removal of unbound receptor by centrifugation
(2 min, 12,000 
 
g
 
, 20
 
8
 
C) and counting of bacteria-associated radio-
activity in a Beckman liquid scintillation counter (Beckman Instru-
ments, Fullerton, CA). Radioactivity bound in the presence of 100
 
m
 
g/ml heparan sulfate was considered nonspecific (usually 
 
z
 
200
cpm) and was subtracted.
 
Infection Assays.
 
Infection of Chang cells maintained on cov-
erslips in 24-well plates in 1 ml of Hepes buffer or RPMI 1640
(tissue culture medium) plus 0.1% IsoVitaleX was initiated by
adding gonococci at a bacterium to epithelial cell ratio of 100:1.
After 2 or 3 h of infection, cells were rinsed three times with 1 ml
DPBS and fixed in 0.1% glutaraldehyde/1% paraformaldehyde in
DPBS for at least 1 h at 20
 
8
 
C. The number of extra- and intracel-
lular bacteria was determined microscopically after immunogold
silverstaining and/or crystal violet staining as detailed previously
(55, 56). Values are given as the mean number of gonococci per
epithelial cell and represent the mean 
 
6
 
 SEM of at least three ex-
periments. When appropriate, phosphorus containing compounds
(sodium phosphate (NaH
 
2
 
PO
 
4
 
 
 
1
 
 Na
 
2
 
HPO
 
4
 
, pH 7.4), GTP, GDP,
GMP, ATP, UTP, sodium tripolyphosphate, and sodium 
 
b
 
-glyc-
erophosphate) from buffered stock solutions (pH 7.4) were added
just before the addition of the bacteria. When AHU-starved bac-
teria were tested, no IsoVitaleX was present during the assay. In-
fections with iron-starved bacteria were performed in Hepes
buffer plus 30 
 
m
 
M Deferoxamine.
 
GTP-binding Assay.
 
Binding of GTP to gonococci was de-
termined by cross-linking of the ribose moiety of the nucleotide
to lysine residues in the vicinity of the nucleotide binding site af-
ter the procedure of Peter et al. (57) as applied by Rudel et al.
(44) with some modifications. In brief, 2 
 
3 
 
10
 
8
 
 agar plate–grown
gonococci were suspended in Hepes buffer, washed once, and re-
suspended in 50 
 
m
 
l Hepes buffer. Labeling was initiated by adding
2.5 
 
m
 
Ci (10 nM, final concentration) of 
 
g
 
-[
 
32
 
P]GTP (5,000 Ci/
mmol, Amersham Pharmacia Biotech, Arlington Heights, IL).
After 8 min of incubation in a 37
 
8
 
C waterbath, the ribose moiety
was oxidized (1 min) by the addition of 1 mM of sodium perio-
date, resulting in the formation of a reactive dialdehyde. The
Schiff base formed between the oxidized ribose and a nearby
lysine residue was stabilized (1 min) with 20 mM of sodium cy-
anoborohydride (Sigma Chemical Co.), and the reaction was
stopped by the addition of 20 mM of sodium borohydride, fol-
lowed by 5 min of incubation on ice, and centrifugation (2 min,
12,000 
 
g
 
, 20
 
8
 
C). Pellets were washed three times with 150 
 
m
 
l
Hepes buffer to remove unbound label, lysed in sample buffer, and
5 
 
3 
 
10
 
7
 
 bacteria were subjected to SDS-PAGE (12.5% gels) and
autoradiography. Reactive bands were analyzed by densitometry
using an Alpha Imager 2000 (Alpha Innotech, San Leandro, CA)
and accompanying software. When appropriate, 2 
 
m
 
l of unlabeled
phosphorus containing compound (or an equivalent amount of
buffer) was added 2 min before the addition of the 
 
g
 
-[
 
32
 
P]GTP to
complete the binding of label. Experiments performed without
the addition of sodium cyanoborohydride served as controls.
 
Results
 
Opa-independent Gonococcal Invasion of Human Epithelial
Cells.
 
Infection of cultured Chang epithelial cells with
isogenic variants of gonococcus strain VP1 that carry differ-
ent Opa protein phenotypes resulted in efficient bacterial
invasion of VP1-Opa27.5 but none of the other variants
when the experiments were performed in tissue culture
medium (Fig. 1, 
 
A
 
 and 
 
B
 
). These data are consistent with 
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the proposed role for this Opa protein as a gonococcal ad-
hesin/invasin (12, 13) and confirm the notion that Opa
protein variation contributes to the cell tropism displayed
by gonococci (11, 15, 55). However, during our investiga-
tions of the molecular mechanism behind the invasion event,
we noticed that when the infection experiments were per-
formed in Hepes-buffered saline instead of tissue culture me-
dium, gonococcus strain VP1 was efficiently endocytosed by
the eukaryotic cells irrespective of the Opa phenotype. Anal-
ysis of the invasive behavior of the same set of isogenic VP1
variants described above clearly demonstrated that under
these conditions Opa proteins were not required to facilitate
bacterial internalization (Fig. 1 
 
C
 
). Similar results were ob-
tained for gonococcus strain FA19 (Fig. 2). In contrast, when
Opa variants of the widely investigated strain MS11 were
tested, the characteristic MS11-Opa30 dependence of the
entry process (12) was maintained and MS11-Opa
 
2
 
 variants
were unable to invade the epithelial cells even when the as-
say was performed in Hepes buffer (Fig. 2), suggesting that
only certain gonococcal strains have evolved an alternative,
Opa-independent invasion mechanism.
 
Potential Role of the Bacterial Porin P.IA in Gonococcal Inva-
sion of Epithelial Cells.
 
In search for the bacterial ligand(s)
that facilitated the Opa-independent invasion, we focused
on the apparent variability in the activity of this invasion
mechanism among gonococcal strains. For this purpose, we
selected isogenic variants of 12 gonococcal isolates that ei-
ther lacked Opa protein (Opa
 
2
 
) or produced a member of
the Opa protein family that bound epithelial cell proteogly-
can-receptors (Opa
 
HS
 
), a feature that we previously dem-
onstrated to be required for Opa-mediated entry into vari-
ous cell types (55). Infection experiments with the isolates
showed that all 12 strains were able to invade Chang epi-
thelial cells in an Opa
 
HS-dependent fashion (Fig. 2 A). In
contrast, only 6 out of 12 variants that lacked Opa protein
were able to enter the cells and again only when the assays
were performed in Hepes buffer (Fig. 2 B). Detailed com-
parison of the characteristics of the various strains, includ-
ing auxotype, electrophoretic outer membrane profile, P.I
subtype, and LPS phenotype, revealed a 100% correlation
between the Opa-independent invasion and the type of P.I
porin produced by the strains. All six strains that carried the
Figure 1. Opa-independent invasion of Chang cells by gonococcus
strain VP1. (A) Immunoblot of whole cell lysates of the VP1–Opa variants
(Opa30, Opa29, Opa27.5, Opa27, Opa2) used in the infection experi-
ments. Opa proteins were detected using the mAb 4B12/CII, HRP-con-
jugated goat anti–mouse IgG, and Supersignal. (B and C) Bacterial adher-
ence to and entry of the VP1–Opa variants into Chang epithelial cells
maintained in tissue culture medium (B) and Hepes buffer (C) at 2 h of
infection. Data are expressed as the number of gonococci (Gc) per cell and
are the mean 6 SEM of 6–10 experiments.
Figure 2. Relationship between P.I phenotype and Opa-independent
gonococcal invasion. Bacterial adherence to and entry into Chang cells
was determined at 2 h of infection in Hepes buffer for 12 gonococcal iso-
lates with a P.IA or P.IB phenotype. For each of the strains, variants that
expressed either (A) a heparan sulfate–binding Opa (OpaHS) that confers
entry through proteoglycan receptors or (B) no Opa protein were tested.
The OpaHS phenotype was confirmed through binding assays using puri-
fied 35SO4-labeled proteoglycan ectodomain isolated from Chang epithe-
lial cells as a ligand (reference 55 and data not shown). Values are the
mean 6 SEM of three to eight experiments.945 van Putten et al.
P.IA subtype of porin were able to enter the cells in the ab-
sence of Opa protein, whereas all strains with a P.IB type of
porin required an OpaHS for bacterial invasion of Chang
cells (Fig. 2). This finding is of particular interest as molec-
ular epidemiological studies indicate an association between
the P.IA protein and the intrinsic ability of a gonococcal
strain to disseminate from the initial site of infection to
other body sites (45–48).
Allelic Replacement of P.IA and P.IB Genes. To ascertain
that P.IA, rather than possible associated traits, conferred
gonococcal invasion of epithelial cells, we determined the
invasive behavior of a complete set of gonococcal recombi-
nants in which the P.IA gene (por1A) of strain FA19 and
the P.IB gene (por1B) of strain MS11 were interchanged by
allelic replacement (49). Strains in which the por gene was
replaced with its endogenous copy with a genetically
linked resistance marker, served as controls. The P.I sub-
type of the recombinant strains was confirmed by SDS-
PAGE and Western blotting using P.IA- and P.IB-specific
antibodies (Fig. 3, A and B). Electrophoretic analysis re-
vealed no detectable changes in LPS associated with the
conversion of the P.I phenotype (data not shown). Using
Opa2 variants, recombinant FA19 that carried its origi-
nal por1A was highly invasive, whereas the recombinant
MS11-P.IB was not internalized by the epithelial cells,
consistent with the behavior of their corresponding parents
(Fig. 3, C and E). Of particular interest, expression of
por1B derived from MS11 in the FA19-Opa2 background
resulted in a complete loss of bacterial invasiveness from
this strain. Conversely, MS11-Opa2 that had acquired the
por1A of FA19 gained the ability to enter the host cells
(Fig. 3, C and E). To ensure that the allelic replacement
procedure had not caused a general defect in bacterial inva-
sion, recombinants with OpaHS phenotypes were isolated
and assessed for Opa-dependent invasion. Infection experi-
ments showed that all four recombinants (MS11-P.IB,
MS11-P.IA, FA19-P.IA, and FA19-P.IB) were able to en-
ter the Chang epithelial cells in an Opa-dependent fashion
(Fig. 3, D and F). Together, these data strongly suggest that
P.I is a conclusive determinant of the Opa-independent
entry mechanism.
Invasive Behavior of Rmp Knockout Mutants. In the bac-
terial outer membrane, most of the P.I porins are present as
trimers that are noncovalently complexed with the Rmp
outer membrane protein (58, 59), and Rmp surface expo-
sure (60) may vary with the P.I phenotype. Thus, it can be
argued that P.IA-dependent invasion may actually be me-
diated through Rmp. To investigate this concept, we con-
structed a set of gonococcal recombinants in which 196 out
of 214 codons encoding the mature Rmp were deleted and
replaced by a chloramphenicol resistance cassette (Fig. 4
A). Mutation of Rmp was verified by genetic analysis (data
not shown) and Western blotting using an Rmp-specific
antibody (Fig. 4 B). Infection experiments with rmp knock-
outs that lacked Opa protein at their surface demonstrated
efficient P.IA-mediated invasion of Chang cells in Hepes
buffer, but not in tissue culture medium (Fig. 4 C). The
corresponding Rmp-deficient MS11-P.IB strain was still
unable to enter epithelial cells irrespective of the medium
employed (Fig. 4 C), indicating that Rmp did not conceal
possible invasive properties of P.IB. It should be noted that
infection assays with variants with the appropriate OpaHS
phenotype showed up to a 50% reduction in Opa-medi-
ated gonococcal uptake for the Rmp mutants compared
with their parents in both Hepes buffer and tissue culture
medium (Fig. 4 C). This effect was probably associated
with the reduced growth rate observed for these recombi-
nant strains, as efficient bacterial growth is required to
achieve maximal functional OpaHS activity (24). Together,
the results strongly support the notion that the P.IA mole-
cule drives the Opa-independent invasion event.
Regulation of P.IA-mediated Gonococcal Invasion by Phos-
phate. Systematic complementation of the Hepes buffer
used in the invasion assay with constituents of the tissue
Figure 3. Invasion of gonococci carrying recombinant P.I proteins. A/B.
Western blot of whole cell lysates of the P.I recombinants demonstrating
the presence of P.IA and P.IB in the MS11 and FA19 backgrounds. Blot
A was incubated with the P.IA-specific antibody 1EA; blot B with the
P.IB-specific antibody 5.51. (C and D) Binding of 35SO4-labeled heparan
sulfate proteoglycan (HSPG) receptor to selected P.I recombinants that
produce the heparan sulfate–binding Opa (OpaHS) or lack Opa proteins
(Opa2). Binding was measured after 10 min of incubation and data are
the mean 6 SEM of three to eight experiments. (E and F) Adherence to
and invasion of Chang cells by the P.I recombinant strains with the differ-
ent Opa phenotypes at 2 h infection in Hepes buffer. Values are mean 6
SEM of 5–12 experiments.946 Porin-mediated Invasion of N. gonorrhoeae
culture medium revealed that the addition of phosphate
completely abrogated the activity of the P.IA-dependent
entry mechanism. Dose–response experiments showed half-
maximal inhibition of the VP1-Opa2 entry at 0.8 mM so-
dium phosphate, whereas .95% inhibition was achieved at
5.0 mM of phosphate (Fig. 5 A). The addition of phos-
phate to the infection system did not affect the Opa-depen-
dent entry process (Fig. 5 A), explaining the efficient entry
of VP1-Opa27.5 that was observed when infection assays
were performed in tissue culture medium, which contains
relatively high concentrations of sodium phosphate (5.6
mM in RPMI 1640).
The identification of a phosphate-sensitive invasion mech-
anism in strains bearing P.IA, but not P.IB, suggested that
phosphate modulates the invasive behavior of the bacteria
rather than the phagocytic activity of the epithelial cells.
Theoretically, phosphate limitation may facilitate P.IA-
mediated invasion through changes related to the starvation
induced cessation of bacterial growth, a phosphate-specific
adaptive response, or, possibly, a direct modulation of
porin function. Detailed analysis of the outer membrane
profiles of phosphate-starved and -nonstarved gonococci
revealed no obvious differences (data not shown). Possible
effects of bacterial growth rate were examined by testing
bacterial invasiveness after introduction of other forms of
starvation. Iron-deprivation, induced by the addition of the
iron chelator Deferoxamine (30 mM) to the medium (strain
VP1), or depletion of the bacteria for essential arginine, hy-
poxanthine, and uracil (strain FA19), which resulted in
similar low bacterial growth rates as caused by phosphate
starvation (data not shown), did not facilitate Opa-inde-
pendent invasion unless additional phosphate limitation was
imposed (Fig. 5 B). Thus, the invasion mechanism ap-
peared to be active under low phosphate conditions only.
Infection assays in the presence of a number of different
phosphorus-containing compounds demonstrated that, in
addition to inorganic phosphate, the nucleotides ATP,
GTP, GDP, and GMP, and tripolyphosphate effectively in-
hibited P.IA-mediated gonococcal invasion (Table 2). Other
compounds, such as UTP, and b-glycerophosphate al-
lowed efficient invasion of VP1-Opa2 at molar concentra-
tions at which sodium phosphate was inhibitory (Table 2).
Further analysis of the effect of the nucleotides showed an
apparent direct correlation between the number of phos-
phate groups in the guanosine moiety and the level of inva-
sion with values for half maximal inhibition of invasion
Figure 4. Role of the P.I-associated protein Rmp in the P.I-mediated
invasion of epithelial cells. (A) Diagram of the deletion in rmp and inser-
tion of the chloramphenicol resistance cassette (cat) resulting in the Rmp-
negative phenotype. The numbering of nucleotides is relative to the start
of the ORF. (B) Western blot of whole cell lysates of the parent (WT)
and Rmp-deficient (rmp) FA19 (P.IA) and MS11 (P.IB). Rmp was de-
tected with the mAb 4C7E. (C) Effect of mutation of rmp on the P.IA
(FA19-Opa2) and proteoglycan-mediated (MS11-OpaHS) adherence and
invasion of Chang cells (2 h of infection). Assays were performed in
Hepes buffer (H) and tissue culture medium (M). Infection with the pa-
rental strains (WT) served as controls. Data are the mean 6 SEM of three
to five experiments.
Figure 5. Sensitivity of the P.I-mediated invasion to phosphate. (A)
Adherence and entry into Chang cells of VP1 lacking Opa protein
(Opa2) and a variant producing OpaHS in the absence and presence of in-
creasing concentrations of sodium phosphate (Pi). (B) Effect of iron (Fe2)
(strain VP1) and AHU starvation (strain FA19) on the P.IA-mediated
bacterial adherence and entry into Chang cells in the absence and pres-
ence of 5 mM phosphate. Bacteria grown in Hepes medium served as
controls (Ctrl). Values are the mean 6 SEM of four to eight experiments.947 van Putten et al.
(Inv50) at 0.05 mM, 0.4 mM, and 0.8 mM for GTP, GDP,
and GMP, respectively (Table 2). Additional experiments
with the highly effective inhibitor tripolyphosphate (Inv50
at 0.05 mM) indicated that this compound was not effi-
ciently metabolized by the gonococci as inferred from its
inability to support bacterial growth when added as a sole
phosphate source to a phosphate-deficient chemically de-
fined medium (data not shown). Thus, metabolization of
phosphate compounds appeared not to be required for in-
hibition of the invasion event.
GTP Binding to P.I Is Sensitive to Phosphate. The gono-
coccal porin has been demonstrated to bind GTP and this
binding appears to regulate the function of the ion channel
(44). We took advantage of this property to test whether
the inhibition of the bacterial invasion by phosphate could
have occurred through a direct effect on the porin. Thus,
we covalently cross-linked g-[32P]GTP to the recombinant
P.IA and P.IB proteins produced by strain MS11 in the ab-
sence and presence of phosphate, using the cyanoborohy-
dride coupling procedure (57). Analysis of labeled bacterial
cell lysates separated by SDS-PAGE and subjected to auto-
radiography showed that in the absence of phosphate,
g-[32P]GTP was cross-linked to both the P.IA and P.IB
porins, with coupling to P.IA approximately five times
more effective than to P.IB (Fig. 6 A). This difference in
coupling efficiency among P.I subtypes was maintained for
all strains that were tested (four P.IA and four P.IB; Fig. 6
B). In contrast, when inorganic phosphate was included in
the coupling procedure, GTP binding to P.IA was strongly
reduced (Fig. 6 C). A similar inhibition was observed for
ATP, GTP, and tripolyphosphate (GDP and GMP were
not tested) (Fig. 6 C). In contrast, UTP and b-glycero-
phosphate, compounds that were unable to block the inva-
sion process, did not interfere with the cross-linking of
GTP (Fig. 6 C). Thus, phosphate compounds that blocked
P.IA-mediated invasion also inhibited the binding of GTP
to the porin. Together, the data are consistent with a regu-
latory mechanism in which distinct phosphorus containing
molecules modulate the P.IA-mediated invasion through
an effect on the porin, possibly by mimicking the effect of
GTP on porin function.
Discussion
Porins of Gram-negative bacteria function as aqueous
transmembrane protein channels that facilitate transport of
Table 2. Inhibitory Effect of Phosphorus-Containing Compounds 
on P.IA-mediated Invasion
Compound Dose Invasion Inv50*
mM Gc/cell mM
None 0 15.8 6 1.2 –
Pi 5 2.5 6 0.3 0.95
GTP 0.5 0.2 6 0.1 0.03
GDP 1 1.0 6 0.5 0.09
GMP 1 2.3 6 1.2 0.57
ATP 5 0 ND
UTP 5 16.6 6 1.6 –
TPP 0.5 1.3 6 0.5 0.05
bG-P 5 9.4 6 2.0 .5
Gonococcal invasion was determined at 3 h of infection of Chang cells
with VP1-Opa2 in the absence and presence of various putative inhibi-
tory reagents. Values are the mean 6 SEM of four to eight experi-
ments.
*Inv50, dose at which 50% reduction of invasion occurs; Gc, gono-
cocci; Pi, sodium phosphate; TPP, tripolyphosphate; bG-P, b-glycero-
phosphate.
Figure 6. Binding of GTP to
P.I and its sensitivity to phospho-
rus-containing compounds. (A)
Autoradiogram of electropho-
resed whole cell lysates of MS11
carrying either recombinant P.IA
(MS-A) or P.IB (MS-B) after
cross-linking of g-[32P]GTP to
the bacteria. Binding in the ab-
sence of sodium cyanoborohy-
dride (CBH) served as a control.
(B) Autoradiogram showing the
binding of g-[32P]GTP to P.I of
four P.IA (VP1, 7122, 7929, and
FA19) and four P.IB (MS11,
FA1090, 5590, and 1291) isolates
(bottom). Binding was quantitated
by densitometry setting binding
in the absence of CBH at zero
value (top). (C) Autoradiogram
showing the binding of g-[32P]GTP to MS11-P.IA (MS-A) in the absence (2) and presence of 20 mM sodium phosphate (Pi), 2 mM ATP, 2 mM UTP,
2 mM GTP, 2 mM sodium tripolyphosphate (TPP), and 20 mM sodium b-glycerophosphate (bG-P) (bottom). Binding was quantitated by densitometry set-
ting binding in the absence of CBH at zero value (top).948 Porin-mediated Invasion of N. gonorrhoeae
certain solutes and macromolecules across the outer mem-
brane barrier. In the past decade, there has been much
speculation about additional biological functions of porins,
particularly in bacterial pathogenesis. For the neisserial P.I
porins, these speculations were largely based on observa-
tions that P.I proteins spontaneously translocate as func-
tional voltage-gated ion channels into planar lipid bilayers
and plasma membranes of eukaryotic cells (36, 40, 44), and
impair neutrophil function by causing a transient change in
membrane potential and interference with cell signaling
events (41–43). By a mechanism seemingly unrelated to its
channel forming activity (61), the neisserial P.I proteins
also exhibit mitogenic potential and stimulate immuno-
globulin secretion by lymphocytes, in line with their strong
efficacy as adjuvants (62, 63). However, these interesting
and important findings concerning P.I biology were ob-
tained primarily with purified protein and have not been
demonstrated for P.I in the context of a viable microorgan-
ism. Thus, their significance for the pathogenesis of neisser-
ial disease and their value as a potential target for infection
intervention at the cellular level remain elusive.
Here we provide evidence that the gonococcal P.I porin
facilitates bacterial invasion into eukaryotic cells. This novel
mechanism of invasion was specific for strains bearing the
P.IA subtype of porin, independent of the Opa phenotype,
and was only operational under conditions of low phos-
phate. The invasive phenotype was generated by expres-
sion of the por1A gene, whereas invasiveness was lost when
por1A was replaced with por1B. This, in conjunction with
the unaltered behavior of mutants deficient in the P.I-asso-
ciated protein Rmp, confirmed P.IA as the prime determi-
nant of the invasion event. The striking resemblance in
modulation of the bacterial invasion and of the binding of
the putative regulator of channel function GTP to the P.I
protein by a panel of phosphate-containing compounds
suggested the occurrence of a direct effect of phosphate on
porin function, thus providing a potential basis for the
phosphate sensitivity of this invasion mechanism. The spe-
cific invasion of epithelial cells by P.IA-bearing strains may
be of particular interest as it coincides with the more inva-
sive behavior of these strains in the setting of the clinical
infection. The propensity of gonococci to disseminate from
the initial focus of infection towards various body sites is
typically associated with the isolation of strains with a P.IA
phenotype (46–49).
The porin-mediated invasion mechanism reported here
clearly differs from the well-documented uptake conferred
by gonococcal Opa outer membrane proteins. Opa pro-
teins comprise a family of up to 11 members that are vari-
ably expressed and are structurally composed of relatively
conserved transmembrane protein segments interspersed
with several variable surface-exposed regions that provide
cell binding specificity. Opa proteins facilitate bacterial in-
vasion of mammalian cells through recognition of distinct
cell surface receptors, including heparan sulfate proteogly-
cans (55, 64) and various members of the CD66 (CEA) re-
ceptor family (65–68), dependent on the Opa phenotype.
Our data confirm the requirement for heparan sulfate–spe-
cific Opa proteins (OpaHS) for proteoglycan-mediated en-
try into Chang epithelial cells, and indicate that this class of
proteins is ubiquitous among gonococcal isolates. Based on
immunomorphological observations, it has been postulated
that P.I may participate in the Opa-mediated uptake (52).
However, if present at all, this event is seemingly unrelated
to the P.IA-mediated invasion mechanism, as our findings
demonstrate that the Opa-dependent uptake was equally
effective for P.IA- and P.IB-bearing strains, and indepen-
dent of the phosphate concentration in the medium, in
contrast to the P.IA-mediated event. The Opa-mediated
uptake via the CD66 receptor pathway clearly does not re-
quire P.I, as evidenced by the efficient internalization of E.
coli–Opa recombinants that lack gonococcal porin (66, 68).
In the bacterial outer membrane, the gonococcal porin is
intimately associated with the outer membrane protein
Rmp and with lipopolysaccharide (58, 59, 69). Rmp is a
31,000-dalton outer membrane protein that is conserved
among the pathogenic Neisseria species and has gained
much attention as a target of so-called blocking antibodies.
Binding of these antibodies to the bacterial cell surface does
not lead to the formation of a lytic complement attack
complex and blocks the bactericidal activity of antibodies
directed against other surface antigens, including P.I (50,
70). Because of the tight association with the porin protein,
it was essential to discern whether the uptake event was
mediated through P.I and/or Rmp, particularly as antibod-
ies to both P.I and Rmp have been reported to afford
Chang cells some protection against gonococcal challenge
(71–73). However, the efficient P.IA dependent uptake of
the Rmp knockout mutant unequivocally excluded Rmp
as a participant in the entry process. These experiments also
demonstrated that Rmp does not conceal cryptic P.IB in-
vasion promoting activity, as MS11-P.IB deficient in Rmp
was still unable to invade the epithelial cells. Whether LPS
contributes to the invasive behavior of P.IA strains remains
to be explored. LPS analysis of the P.I recombinant strains
showed identical LPS profiles for both P.IA- and P.IB-car-
rying strains, but subtle P.I phenotype-related changes in
LPS structure cannot be excluded.
A key observation in our work was that P.IA-mediated
invasion was only apparent under conditions of low phos-
phate availability, even when iron or amino-acid starvation
were imposed on the bacteria. Experiments in which phos-
phate availability was limited either before or during the
invasion assay suggested that the presence of phosphate in
the infection assay was the critical determinant of invasion
(data not shown). Titration of the phosphate indicated that
its modulatory effect occurred within the physiological
range of phosphate concentrations present in human se-
rum, with half maximal inhibition of bacterial entry at
z0.8 mM of inorganic phosphate. The exact molecular ba-
sis for the phosphate sensitivity has yet to be resolved. All
our data are consistent with a model in which phosphate
directly targets P.IA. The phosphate-sensitive invasion was
associated with transfer of the por1A gene, as indicated by
the allelic replacement experiments, and cross-linking
experiments indicated that inorganic phosphates as well949 van Putten et al.
as several other phosphorylated molecules prevented the
binding of GTP to the porin. The possibility that the phos-
phate limitation induced a specific metabolic response
modulating the invasion process is less likely as evidenced
by the effective inhibition of bacterial invasion by tripoly-
phosphate at concentrations that did not support bacterial
growth.
Several mechanisms can be envisioned by which phos-
phate modulates porin function. The simplest mechanism
may be that P.IA carries a phosphate binding site that, if
occupied, prevents the interaction of the P.IA porin with a
specific cell surface receptor. This concept demands the
presence of a surface-exposed binding domain on P.I that is
conserved among P.IA strains and absent from P.IB. This is
not improbable, as certain mAbs directed against surface-
exposed epitopes are specific for, and broadly cross-reactive
among, P.IA strains (72). In a more complex scenario, the
modulatory effect of phosphate may be related to the chan-
nel-forming activity of the porin and its ability to insert
into mammalian cell membranes. The neisserial P.I protein
differs from most bacterial porins in that its gating function
appears to be modulated by binding of nucleoside triphos-
phates, i.e., GTP and ATP (44). Patch clamp studies using
purified P.IA have demonstrated that GTP may regulate
the substate (open/closed) of the channel (44). Our cross-
linking experiments indicate that GTP binding is much
more efficient in P.IA versus P.IB strains and is inhibited by
various phosphorus containing molecules. This inhibition
correlates remarkably well with their effect on bacterial in-
vasion. We currently favor the working hypothesis that the
function of P.IA as an invasin may require the porin to be
in an open state, making potential receptor binding sites ac-
cessible and/or allowing efficient insertion of functional
ion channels into the host cell plasma membrane. In this
model, the inhibition of invasion by phosphorylated com-
pounds would be caused by a phosphate-induced closure of
channels reminiscent of the reported closing effect of GTP
on P.IA (44). Conversely, in the absence of the regulatory
phosphorylated compounds maximum opening of the por-
ins would be achieved, facilitating effective bacterial inva-
sion. The proposed phosphate-dependent regulation in P.I
channel activity is consistent with the notion that, in other
bacterial species, the vast majority of porins in the outer
membrane may be in the closed state when the microor-
ganism are grown in rich media and only open under cer-
tain environmental conditions such as a shortage of nutri-
ents (74–76). Whether the observed increased binding of
GTP (Fig. 6) and the reported 10 to 20 times higher rate of
translocation into lipid membranes of the P.IA porin versus
its P.IB counterpart (40) are sufficient to account for the
unique invasive properties associated with P.IA strains
awaits future investigation.
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